Journal
SCIENCE
Volume 330, Issue 6007, Pages 1095-1099Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1191793
Keywords
-
Categories
Funding
- National Health and Medical Research Council (NHMRC) Australia [356202, 461221]
- Leukemia and Lymphoma Society [7413]
- NIH [CA43540, CA80188]
- NHMRC
- Pfizer Australia
- Olle Engkvist Byggmastare Foundation
- Wenner-Gren Foundation
- German Academic Exchange Service
- Charles and Sylvia Viertel Charitable Foundation
- Boehringer Ingelheim
Ask authors/readers for more resources
Lymphocyte survival during immune responses is controlled by the relative expression of pro- and anti-apoptotic molecules, regulating the magnitude, quality, and duration of the response. We investigated the consequences of deleting genes encoding the anti-apoptotic molecules Mcl1 and Bcl2l1 (Bcl-xL) from B cells using an inducible system synchronized with expression of activation-induced cytidine deaminase (Aicda) after immunization. This revealed Mcl1 and not Bcl2l1 to be indispensable for the formation and persistence of germinal centers (GCs). Limiting Mcl1 expression reduced the magnitude of the GC response with an equivalent, but not greater, effect on memory B cell formation and no effect on persistence. Our results identify Mcl1 as the main anti-apoptotic regulator of activated B cell survival and suggest distinct mechanisms controlling survival of GC and memory B cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available